The power and promise of social media in oncologyMay 3, 2021Patient & Survivor CareBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Hyperprogression on immunotherapy: When outcomes are much worseApril 30, 2021ImmunotherapyNonmelanoma Skin CancerMelanomaBreast CancerGastroenterologyGastrointestinal CancerGenitourinary Cancer
New data dim hopes for ‘triumph of drug discovery’April 14, 2021Patient & Survivor CareLung CancerGastrointestinal Cancer
Personalized cancer vaccine shows early promise across tumor typesApril 14, 2021Patient & Survivor CareBreast CancerGenitourinary CancerLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersLung Cancer
Rankings of most common cancers to shift over next 20 yearsApril 14, 2021Breast CancerLung CancerMelanoma
Steroid-refractory pneumonitis from ICIs: Experience at major centersApril 9, 2021Patient & Survivor CareLung CancerNonmelanoma Skin CancerMelanomaGastrointestinal CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell Disorders
